Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Sogroya

(somapacitan-beco)Orphan drugstandard

Novo Nordisk Pharmaceuticals

12.1 Mechanism of Action Somapacitan-beco binds to a dimeric GH receptor in the cell membrane of target cells resulting in intracellular signal transd...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome.
Search all trials →
Search clinical trials for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome

Recent News & Research

No recent news articles indexed yet for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome.
Search PubMed for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome

Browse all Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome news →

Specialist Network

No specialists currently listed for Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome.

View all Short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome specialists →

Quick Actions